LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Naturally Fluorescent Coenzyme Level in Mitochondria Indicative of Disease

By LabMedica International staff writers
Posted on 14 Apr 2009
Image: Polarized light micrograph of crystals of the coenzyme nicotinamide adenine dinucleotide (NAD) (Photo courtesy of Alfred Pasieka / SPL).
Image: Polarized light micrograph of crystals of the coenzyme nicotinamide adenine dinucleotide (NAD) (Photo courtesy of Alfred Pasieka / SPL).
To distinguish between normal and cancerous cells, scientists measured the fluorescence of natural nicotinamide adenine dinucleotide (NADH).

NADH is a coenzyme, a non-protein molecule necessary for the functioning of an enzyme found mostly in the inner membrane of mitochondria. In the event of disease or a metabolic disorder, enzymes and their related reactions can become disabled, causing a buildup of unused NADH.

Using a combination of spectroscopy and microscopy techniques, fluorescence was converted into an accurate measure of NADH concentration in live cells. Ahmed Heikal, associate professor of bioengineering, Pennsylvania State University (Pittsburgh, PA, USA) and colleagues found that the average concentration of NADH in breast cancer cells is about twice that in normal breast cells.

"Dysfunctional enzymes in the mitochondria are known to be associated with serious health problems such as cancer and neurodegenerative diseases," said Professor Heikal. "By detecting the level of NADH and its distribution inside living cells, we should be able to monitor the mitochondrial activity and thus the integrity of any given cell, without adding potentially toxic dyes or actually destroying the cell."

One of the main challenges in cancer diagnosis is the ability to differentiate cancer cells from normal ones at the early stages of tumor progression. "If we are given two live cells, one normal and the other cancerous, we could differentiate between the two with confidence," said Professor Heikal.

The team developed a technique called rotational diffusion imaging to establish a direct measure of the concentrations of free and enzyme-bound NADH throughout a living cell, whether in the cytosol (cell fluid) or the mitochondria.

Other neurodegenerative diseases related to mitochondrial anomalies can also be detected with the new technique, which is not limited to detecting cancer. The ability to accurately measure NADH levels in a cell without killing it could have potential implications for related research on human health and drug delivery.

Related Links:
Pennsylvania State University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more